HRI study confirms role of GPs and novel eHealth tools for AF screening to prevent stroke
New research has shown how novel eHealth tools used in rural Australian general practices are helping to reduce gaps in screening and treatment for atrial fibrillation (AF) in people over 65 years of age.
Dr Lining (Arnold) Ju – Young Tall Poppy Science Award
HRI’s Dr Lining (Arnold) Ju has been recognised for his research excellence and public outreach in the Young Tall Poppy Science Awards for his research into heart disease.
Dr Mary Kavurma awarded ACvA Research Catalyst Grant
Dr Mary Kavurma has been awarded an Australian Cardiovascular Alliance Research Catalyst Grant for her research into peripheral artery disease.
Dr Ashish Misra awarded Perpetual IMPACT grant
Dr Ashish Misra, leader of the Atherosclerosis and Vascular Remodelling Unit at HRI, has been awarded the Perpetual IMPACT grant.
Unprecedented drug design minimising side effects
HRI has developed an unprecedented drug design strategy that tailors drugs with fatty acids to minimise side effects.
Heart screen could protect hundreds from stroke
Testing Māori and Pacific people for an irregular heartbeat earlier could spare hundreds of people from stroke each year, a University of Auckland study has found.
Global media interest in HRI’s breakthrough anti-clotting drug for COVID-19
The revolutionary new anti-clotting medicine developed by HRI has attracted global media interest due to its far-reaching impact.
HRI researchers on cusp of worldwide breakthrough in COVID-19 treatment
Researchers at HRI believe they may hold the key to controlling the deadly blood clots caused by COVID-19.
Why our hearts fail: research
Scientists at HRI and The University of Sydney have made new heart failure discoveries in an innovative world-first project examining cryo-preserved human hearts.